Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446654
Status:
COMPLETED
Last Update Posted:
2012-08-06
First Post:
2007-03-09
Brief Title:
Safety of 165 mg 33 CGC-11047 Once Every 2 Weeks vs Once Every 4 Weeks in Patients With CNV Due to AMD
Sponsor:
Progen Pharmaceuticals
Organization:
Progen Pharmaceuticals
Organization Data
Organization:
Progen Pharmaceuticals
Class:
INDUSTRY
Study ID:
47-MD-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Progen Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None